S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS
Fabian Lang,
Heike Pfeifer,
Simon Raffel,
Walter Fiedler,
Maher Hanoun,
Mathias Hänel,
Bernd Spriewald,
Andreas Viardot,
Vladan Vucinic,
Hubert Serve,
Dieter Hoelzer,
Nicola Gökbuget
Affiliations
Fabian Lang
1 Goethe University Hospital, Department of Medicine, Hematology and Oncology, Frankfurt am Main, Germany
Heike Pfeifer
1 Goethe University Hospital, Department of Medicine, Hematology and Oncology, Frankfurt am Main, Germany
Simon Raffel
2 University of Heidelberg, Department of Hematology, Oncology and Rheumatology, Heidelberg, Germany
Walter Fiedler
3 Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Maher Hanoun
4 Universitätsklinikum Essen, Department of Bone Marrow Transplantation, Essen, Germany
Mathias Hänel
5 Küchwald Hospital Chemnitz, Department of Internal Medicine III, Chemnitz, Germany
Bernd Spriewald
6 University Hospital Erlangen, Department of Internal Medicine 5, Erlangen, Germany
Andreas Viardot
7 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany
Vladan Vucinic
8 University Leipzig Medical Center, Clinic and Policlinic for Hematology, Celltherapy and Hemostaseology, Leipzig, Germany
Hubert Serve
1 Goethe University Hospital, Department of Medicine, Hematology and Oncology, Frankfurt am Main, Germany
Dieter Hoelzer
9 Onkologikum, Goethe University, Frankfurt am Main, Germany
Nicola Gökbuget
1 Goethe University Hospital, Department of Medicine, Hematology and Oncology, Frankfurt am Main, Germany
